Download PDF
Synlett 2010(10): 1489-1492  
DOI: 10.1055/s-0029-1219946
LETTER
© Georg Thieme Verlag Stuttgart ˙ New York

Enantioenriched Naphthoquinone Mannich Bases by Organocatalyzed Nucleophilic Additions to in situ Formed Imines

Muhammad Ayaza, Bernhard Westermann*a,b
a Department of Bioorganic Chemistry, Leibniz Institute of Plant Biochemistry, Weinberg 3, 06120 Halle/Saale, Germany
b Institute of Organic Chemistry, Martin-Luther-University Halle-Wittenberg, Kurt-Mothes-Str. 2, 06120 Halle/Saale, Germany
Fax: +49(345)55821309; e-Mail: Bernhard.Westermann@ipb-halle.de;
Further Information

Publication History

Received 4 February 2010
Publication Date:
25 May 2010 (online)

    Permissions and Reprints All articles of this category

Abstract

Organocatalytic nucleophilic addition of 2-hydroxylnaphthaquinone to imines is reported. This new route can be used to produce enantioenriched Mannich bases with excellent yields and moderate enantioselectivities.

Key words

organocatalysis - enantioselective Mannich reaction - 1,4-addition - α-amidosulfone - naphthoquinone

    References and Notes

  • Some late reviews on organocatalysis:
  • 1a Gaunt MJ. Johansson CCC. McNally A. Vo NT. Drug Discovery Today  2007,  12:  8 
    Google Scholar
  • 1b Bertelsen S. Jørgensen KA. Chem. Soc. Rev.  2009,  38:  2178 
    Google Scholar
  • 1c Rios R. Cordova A. Curr. Opin. Drug Discovery Dev.  2009,  12:  824 
    Google Scholar
  • 1d Liu XH. Lin LL. Feng XM. Chem. Commun.  2009,  6145 
    Google Scholar
  • 1e Xu LW. Luo J. Lu YX. Chem. Commun.  2009,  1807 
    Google Scholar
  • 1f Zhang ZG. Schreiner PR. Chem. Soc. Rev.  2009,  38:  1187 
    Google Scholar
  • 1g Connon SJ. Synlett  2009,  354 
    Google Scholar
  • 2a Mase N. Tanaka F. Barbas CF. Angew. Chem. Int. Ed.  2004,  43:  2420 
    Google Scholar
  • 2b Northrup AB. MacMillan DWC. Science  2004,  305:  1752 
    Google Scholar
  • 2c Wang J. Li H. Zu LS. Wang W. Adv. Synth. Catal.  2006,  348:  425 
    Google Scholar
  • 2d Enders D. Seki A. Synlett  2002,  26 
    Google Scholar
  • 2e List B. J. Am. Chem. Soc.  2000,  122:  9336 
    Google Scholar
  • 2f Brochu MP. Brown SP. MacMillan DWC. J. Am. Chem. Soc.  2004,  126:  4108 
    Google Scholar
  • 2g Bertelsen S. Halland SN. Stephan B. Marigo M. Braunton A. Jørgensen KA. Chem. Commun.  2005,  4821 
    Google Scholar
  • 2h Westermann B. Neuhaus C. Angew. Chem. Int. Ed.  2005,  44:  4077 
    Google Scholar
  • 2i Clapham B. Cho CW. Janda KD. J. Org. Chem.  2001,  66:  868 
    Google Scholar
  • 3a Ye J. Dixon DJ. Hynes PS. Chem. Commun.  2005,  4481 
    Google Scholar
  • 3b Chen Y. Tian SK. Deng L. J. Am. Chem. Soc.  2000,  122:  9542 
    Google Scholar
  • 4a Uraguchi D. Terada M. J. Am. Chem. Soc.  2004,  126:  5356 
    Google Scholar
  • 4b Storer RI. Carrera DE. Ni Y. MacMillan DWC. J. Am. Chem. Soc.  2006,  128:  84 
    Google Scholar
  • 4c Rueping M. Sugiono E. Azap C. Theissmann T. Bolte M. Org. Lett.  2005,  7:  3781 
    Google Scholar
  • 4d Akiyama T. Morita H. Itoh J. Fuchibe K. Org. Lett.  2005,  7:  2583 
    Google Scholar
  • 4e Wang J. Li H. Yu X.-H. Zu L.-S. Wang W. Org. Lett.  2005,  7:  4293 
    Google Scholar
  • 5a Yoon TP. Jacobsen EN. Angew. Chem. Int. Ed.  2005,  44:  466 
    Google Scholar
  • 5b Okino T. Nakamura S. Furukawa T. Takemoto Y. Org. Lett.  2004,  6:  625 
    Google Scholar
  • 5c Berkessel A. Cleemann F. Mukherjee S. Müller TN. Lex J. Angew. Chem. Int. Ed.  2005,  44:  807 
    Google Scholar
  • 5d Hoashi Y. Okino T. Takemoto Y. Angew. Chem. Int. Ed.  2005,  44:  4032 
    Google Scholar
  • 5e Okino T. Hoashi Y. Furukawa T. Xu X. Takemoto Y. J. Am. Chem. Soc.  2005,  127:  119 
    Google Scholar
  • 5f Berkessel A. Mukherjee S. Mueller TN. Cleemann F. Roland K. Brandenburg M. Neudoerfl JM. Lex J. Org. Biomol. Chem.  2006,  4:  4319 
    Google Scholar
  • 6 Okino T. Hoashi Y. Takemoto Y. J. Am. Chem. Soc.  2003,  125:  12672 
    CrossrefPubMedGoogle Scholar
  • 7 Zhou WM. Liu H. Du DM. Org. Lett.  2008,  10:  2817 
    CrossrefPubMedGoogle Scholar
  • 8 Kamei H. Koide T. Kojima T. Hashimoto Y. Hasegawa M. Cancer Biother. Radiopharm.  1998,  13:  185 
    CrossrefGoogle Scholar
  • 9a Kayashima T. Mori M. Yoshida H. Mizushina K. Matsubara K. Cancer Lett.  2009,  278:  34 
    Google Scholar
  • 9b Zhao LM. Xiw TP. He YQ. Xu DF. Li SS. Eur. J. Med. Chem.  2009,  1410 
    Google Scholar
  • 10a Bolognesi ML. Lizzi F. Perozzo R. Brun R. Cavalli A. Bioorg. Med. Chem. Lett.  2008,  18:  2272 
    Google Scholar
  • 10b Baramee A. Coppin A. Mortuaire M. Pelinski L. Tomavo S. Brocard J. Bioorg. Med. Chem.  2006,  14:  1294 
    Google Scholar
  • 11 Austin JF. Kim SG. Sinz CJ. Xiao WJ. MacMillan DWC. Proc. Natl. Acad. Sci. U.S.A.  2004,  101:  5482 
    CrossrefPubMedGoogle Scholar
12

Under the same set of conditions, an attempt to carry out the reaction with benzaldehyde-derived α-amidosulfone (Cbz protected) and 1 resulted in 90% yield, however, enantioselectivity of the product was only 22%.

13

General Procedure for Addition of Hydroxynaphthoquinone to in situ Formed Imines In a 4 mL process vial α-amidosulfone (0.1 mmol),
2-hydroxy-1,4-naphthoquinone (1, 0.11 mmol), and catalyst (10 mol%) were dissolved in solvent (0.5 mL). The reaction was allowed to stir at r.t. (except where mentioned otherwise) for 24 h. Completion of the reaction was monitored by TLC after which the reaction mixture was directly subjected to column chromatography (CH2Cl2-MeOH = 99.5:0.5). The products were dissolved in freshly distilled THF (4-5 mL), and Et3N (1.1 equiv) was added. After stirring the reaction mixture at r.t. for 5 min, it was cooled to 0 ˚C and acetyl chloride (1.2 equiv) was added slowly. The reaction mixture was stirred at the same temperature for another 30 min after which the product was filtered and concentrated under reduced pressure. Purification of the product was done by column chromatog-raphy (n-hexane-EtOAc = 90:10). The ee values for all the products were determined by HPLC on a chiral stationary phase [Daicel Chiralpak AD-H, n-hexane-i-PrOH (80:20), flow rate = 1.0 mL/min, λ = 254 nm].
3-(1-{[(Benzyloxy)carbonyl]amino}hexyl)-1,4-dioxo-1,4-dihydronaphthalen-2-yl Acetate (5a) Yellow oil; yield 40.8 mg (91%); [α]D ²0 25.5 (c 0.38, CH2Cl2); ee 65%. ¹H NMR (300 MHz, CDCl3-d): δ = 0.86 (t, J = 6.60 Hz, 3 H), 1.20-1.46 (m, 5 H), 1.60-1.79 (m, 2 H), 1.80-1.97 (m, 1 H), 2.44 (s, 3 H), 4.96-5.20 (m, 3 H), 5.79 (d, J = 9.54 Hz, 1 H), 7.22-7.40 (m, 5 H), 7.66-7.79 (m, 2 H), 8.00-8.14 (m, 2 H). ¹³C NMR (75 MHz, CDCl3-d): δ = 13.9, 20.4, 22.4, 25.8, 31.3, 34.5, 47.8, 66.9, 126.7, 128.1, 128.5, 130.7, 132.0, 134.1, 134.3, 136.3, 136.5, 150.7, 155.8, 167.8, 177.9, 185.1. ESI-MS: m/z (%) = 472.5 (100) [M + Na]+. t R(major) = 8.7 min; t R(minor) = 14.9 min.
3-(1-{[(Benzyloxy)carbonyl]amino}ethyl)-1,4-dioxo-1,4-dihydronaphthalen-2-yl Acetate (5b) Yellow oil; yield 36.2 mg (92%); [α]D ²0 10.8 (c 0.95, CH2Cl2); ee 42%. ¹H NMR (300 MHz, CDCl3-d): δ = 1.49 (d, J = 6.95 Hz, 3 H), 2.45 (s, 3 H), 4.86-5.36 (m, 3 H), 5.90 (d, J = 9.51 Hz, 1 H), 7.28-7.42 (m, 5 H), 7.67-7.83 (m, 2 H), 8.08 (m, 2 H). ¹³C NMR (75 MHz, CDCl3-d): δ = 20.4, 20.6, 43.6, 66.9, 126.7, 128.1, 128.5, 130.6, 132.0, 134.1, 134.4, 136.2, 137.1, 150.1, 155.5, 167.9, 178.1, 184.9. ESI-MS: m/z (%) = 416.4 (100) [M + Na]+. t R(major) = 10.9 min; t R(minor) = 12.9 min.
3-{1-[( tert -Butoxycarbonyl)amino]hexyl}-1,4-dioxo-1,4-dihydronaphthalen-2-yl Acetate (12) Yellow oil; yield 27.8 mg (67%); [α]D ²0 7.2 (c 0.41, CH2Cl2); ee 33%. ¹H NMR (300 MHz, CDCl3-d): δ = 0.84 (t, J = 6.80 Hz, 3 H), 1.36 (m, 6 H), 1.40 (s, 9 H), 1.36-1.40 (m, 2 H), 2.42 (s, 3 H), 5.05 (m, 1 H), 5.49 (d, J = 9.57 Hz, 1 H), 7.78 (m, 2 H), 8.08 (m, 2 H). ¹³C NMR (75 MHz, CDCl3-d): δ = 13.9, 20.4, 22.4, 25.8, 28.3, 30.5, 31.3, 34.8, 47.2, 79.6, 126.7, 130.7, 132.0, 134.0, 134.3, 137.0, 150.6, 155.2, 167.8, 178.1. ESI-MS: m/z (%) = 438.4 (100) [M + Na]+. t R(major) = 4.7 min; t R(minor) = 6.0 min.
3-(1-{[(4-Methylphenyl)sulfonyl]amino}hexyl)-1,4-dioxo-1,4-dihydronaphthalen-2-yl Acetate (13) Yellow oil; yield 41.7 mg (89%); [α]D ²0 -13.7 (c 0.34, CH2Cl2); ee -31%. ¹H NMR (300 MHz, CDCl3-d): δ = 0.82-0.92 (m, 3 H), 1.17-1.51 (m, 3 H), 1.55-1.68 (m, 4 H), 1.88 (dt, J = 9.17, 4.59 Hz, 1 H), 1.93 (s, 3 H), 2.43 (s, 3 H), 4.54 (d, J = 7.34 Hz, 1 H), 5.73 (br s, 1 H), 6.86 (d, J = 7.70 Hz, 2 H), 7.55 (d, J = 8.07 Hz, 2 H), 7.67-7.77 (m, 2 H), 7.83-7.91 (m, 1 H), 7.93-8.01 (m, 1 H). ¹³C NMR (75 MHz, CDCl3-d): δ = 13.9, 20.4, 20.9, 22.3, 25.5, 31.0, 34.8, 50.7, 126.4, 126.6, 127.5, 129.4, 130.3, 131.7, 134.2, 137.1, 143.3, 150.9, 167.5, 176.9. ESI-MS: m/z (%) = 492.3 (100) [M + Na]+. t R(major) = 11.9 min; t R(minor) = 16.3 min.